Episode 492: Novel Biomarkers and Targets in Germ Cell Tumors

Episode 492: Novel Biomarkers and Targets in ...

‏التالي

Episode 517: Casdatifan Clinical Data in RCC and Translational Correlates

Toni Choueiri joins Brian and Tom to discuss a recent Nature paper regarding the novel HIF inhibitor, casdatifan, and biomarkers of response. 

Episode 516: The Influence of Hypoxia on Response and Resistance in RCC

Ari Hakimi and Lyn Voung from MSKCC join Brian and Tom to discuss their recent Cancer Cell paper exploring the mechanistic impact of TKI-induced hypoxia on immune response in RCC. 

‏حلقات موصى بها

Cancer and Exercise - Let’s beat it together. EP #563
BJSM Podcast

In this episode Dr Kyle Winik is joined by Dr Lervasen Pillay, a Sport and Exercise Physician who has a keen interest in Exercise and Cancer. Through the episode they discuss an approach to a patient battling cancer and try to give an approach to change the narrative that exercis ...  عرض المزيد

Beating Prostate Cancer
Nutrition Facts with Dr. Greger

New research on prostate cancer screening and diet. This episode features audio from: The Pros and Cons of Testing PSA Levels for Prostate Cancer Changing a Man’s Diet After a Prostate Cancer Diagnosis Natural Dietary Treatments for Enlarged Prostate BPH Visit the video pages for ...  عرض المزيد

S7 E3: Anti-Ds side effects; knee OA exercise; PSA trends & PCUK interview with Dr Bunmi Olajide & Kevin Howell
NB Hot Topics Podcast

Welcome back to the Hot Topics podcast from NB Medical with Dr Neal Tucker. In this episode, we look at three new pieces of research and have a special interview in conjunction with Prostate Cancer UK. First, do antidepressants have physiological side effects? How do they compare ...  عرض المزيد

Episode 201 -- March 2024 -- Part 1 AFP: American Family Physician
AFP: American Family Physician Podcast

Thiazide diuretics (2:20), pancreatic cancer (4:40), DermTech pigmented lesion assay (8:30), chronic low back pain (17:00), hearing aids (23:40), and blood pressure cuff size (27:50).